QT
CRSP icon

Quantamental Technologies’s CRISPR Therapeutics CRSP Stock Holding History

Quantamental Technologies’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$314K Buy
6,921
+353
+5% +$18.2K 0.3% 133
2023
Q2 		$369K Buy
+6,568
New +$373K 0.15% 231
2021
Q4 		– Sell
-2,221
Closed -$249K – 409
2021
Q3 		$249K Buy
+2,221
New +$279K 0.17% 214
2019
Q1 		– Sell
-500
Closed -$14K – 1527
2018
Q4 		$14K Buy
+500
New +$17.4K 0.01% 1083

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Quantamental Technologies's CRSP Position: Q3 2023 in Review

Quantamental Technologies increased its CRISPR Therapeutics (CRSP) stake by 5.4% in Q3 2023, buying an estimated $18.2K and bringing the position to 6,921 shares worth $314K. The position accounts for 0.3% of the portfolio, ranked #133.

Quantamental Technologies first reported a position in CRSP in Q4 2018 and has held it in 4 quarters since. The position peaked at $369K in Q2 2023. 406 funds tracked by Wall St. Rank hold CRSP as of Q3 2023.

  • Quantamental Technologies held 6,921 shares of CRISPR Therapeutics worth $314K as of Q3 2023.
  • Quantamental Technologies bought 353 CRISPR Therapeutics shares in Q3 2023, an estimated $18.2K.
  • CRISPR Therapeutics made up 0.3% of Quantamental Technologies's portfolio in Q3 2023, its #133 holding.
  • Quantamental Technologies first reported a position in CRISPR Therapeutics in Q4 2018 and has held it in 4 quarters since.
  • Quantamental Technologies's CRISPR Therapeutics position peaked at $369K in Q2 2023.
  • 406 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.